Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.
about
A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophyProteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophyType 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomesPeroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophyHistone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.In Vivo Rodent Models of Skeletal Muscle Adaptation to Decreased UseMuscle cachexia: current concepts of intracellular mechanisms and molecular regulationDistinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophyThe p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteinsIncreased muscle proteolysis after local trauma mainly reflects macrophage-associated lysosomal proteolysisMyostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wastingThe role of insulin and other hormones in the regulation of amino acid and protein metabolism in humans.Effect of age on skeletal muscle proteolysis in extensor digitorum longus muscles of B6C3F1 mice.The Systemic Effect of Burn Injury and Trauma on Muscle and Bone Mass and Composition.FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic ratsMechanisms accelerating muscle atrophy in catabolic diseasesMolecular pathways leading to cancer cachexia.The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in miceActivation of Ras and the mitogen-activated protein kinase pathway promotes protein degradation in muscle cells of Caenorhabditis elegans.Stress-dependent proteolytic processing of the actin assembly protein Lsb1 modulates a yeast prionMuscle-specific calpastatin overexpression prevents diaphragm weakness in cecal ligation puncture-induced sepsis.Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.Catabolic signaling pathways, atrogenes, and ubiquitinated proteins are regulated by the nutritional status in the muscle of the fine flounder.AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts.Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.In vivo regulation of human skeletal muscle gene expression by thyroid hormone.Proteasome inhibition improves diaphragm function in congestive heart failure rats.PKB signaling and atrogene expression in skeletal muscle of aged mice.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Regulation of ubiquitin-proteasome and autophagy pathways after acute LPS and epoxomicin administration in mice.Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Deiodinase knockdown during early zebrafish development affects growth, development, energy metabolism, motility and phototransductionProteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteinsInvestigation of the Expression of Myogenic Transcription Factors, microRNAs and Muscle-Specific E3 Ubiquitin Ligases in the Medial Gastrocnemius and Soleus Muscles following Peripheral Nerve InjuryMolecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures.Denervation-Induced Activation of the Ubiquitin-Proteasome System Reduces Skeletal Muscle Quantity Not Quality.Akt (protein kinase B) isoform phosphorylation and signaling downstream of mTOR (mammalian target of rapamycin) in denervated atrophic and hypertrophic mouse skeletal muscle
P2860
Q24301547-1F37E61A-0645-4D7C-B2E8-CFB4D9F4A922Q24310109-9B0FAF02-0631-4E95-859E-743FD48EAB19Q24555065-D1C65B28-2CA3-4649-BF4B-F05ED6ABAB0EQ24564328-CFA8B2A6-FD28-48C9-8202-5903DB9A66D3Q24634396-150F6E60-F64E-40B3-9C47-8C9483251805Q25257349-3CCE48D6-F76B-4AEA-AF9F-19046569A2DAQ26753187-F09C41AB-E5D1-45FA-8E0B-316C4C3C3A4EQ28141769-9CEEF1C9-A163-4E5E-B96F-D4CF04E57077Q28393718-BB5F6429-6A3A-4F00-BB83-BCA53B701A3CQ28513793-A589CA66-7014-430B-BF32-73191BEC2580Q28564932-7DC2CC50-A249-45D7-B07C-B1CCD80CB2DEQ28588473-D024886F-FDBE-4C39-ACBF-B79EEA317866Q30303928-72FF35B0-4EB8-4AAD-AB9A-F93A7F88D0AAQ30439126-DAEE2B58-34C8-4074-A609-9B240986C3FDQ30760745-390D4E98-32BA-4AC8-809E-90BF1730E958Q33589260-17CA7522-E192-434A-BA6D-7188686FCB48Q33655157-2037925B-006D-4DF2-8108-CC8741C117F0Q33902118-4A3FB44F-2BA5-49D8-BBBD-9C753A7D180AQ33958721-3903F805-19BF-443C-AF91-2C4E63EC54B3Q33990203-0B8B7FEC-ABBA-4C03-A001-523EE5BC335CQ33993411-85295364-95D5-48ED-AD12-EF98209416D6Q34281174-1C56141F-DDBF-4E1F-AC62-A2A1BBCDBF0EQ34283455-7EACBE13-F1B6-4C66-B76E-DCB4F59070D3Q34353928-12B44BA9-64A2-4D95-9D33-727DF0FF20D5Q34400107-7EBAB7F1-24A3-455C-B5BB-D4B586FF1ED4Q34424991-817399B9-A7B7-4164-808E-AD51B549C247Q34614152-D65B72B8-42DF-4393-880B-1C9B04B4D36CQ34665595-B56929D4-6718-48CB-B9C8-E75D0E099321Q35003916-C37DDD38-9445-4BDA-A8F7-C1F4FC20F78CQ35005523-BBEFE490-73AC-4718-A9C1-7E13C9620DB5Q35108745-90E536CC-4B38-4554-9AFF-D8A6F9EBF078Q35122201-09A38E7A-E28A-44F8-AA51-7314D0F60CA6Q35178582-416EB669-52D2-4580-9ADE-EE20C5A5CCD5Q35399141-04069363-DB35-4032-83CC-826F551A1939Q35598034-590F537A-8F54-41A1-AE7D-EABC2988F4D8Q35792179-DE00BD41-F155-401C-811D-CB609D2983A9Q35874839-1023F09E-76F1-44FA-A03B-C708459AF24EQ35893223-4147E4B1-A20A-47C4-997E-FC2666C3A341Q36101539-3EBF1766-DD6F-421B-A385-B2F8181C4117Q36123187-B88CB7C8-5064-47B0-9AD3-049051EA060D
P2860
Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@en
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@nl
type
label
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@en
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@nl
prefLabel
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@en
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@nl
P2093
P2860
P356
P1476
Inhibitors of the proteasome r ...... rophying rat skeletal muscles.
@en
P2093
P2860
P304
P356
10.1172/JCI119513
P407
P577
1997-07-01T00:00:00Z